"Recovery Plasma Treatment" Start of Clinical Research New Coronavirus April 25, 4:51

It has been discovered that groups such as the National Center for Global Health Care will begin clinical research on new treatments for patients with new coronavirus to administer blood components from infected and recovered individuals.
In China, it has been reported to have effects on critically ill patients, and the doctor in charge says that it may be a trump card for treatment of critically ill patients.

This clinical study is being carried out by a group such as the National Center for Global Health and Medicine, which plays a central role in the treatment of novel coronavirus, and was officially approved by the Ethics Committee in the hospital on the 23rd.

This therapeutic method, called "healer's plasma treatment," takes out a component called "plasma" that contains "antibodies" that attack viruses etc. from the blood of people who have been infected by the new coronavirus in the past and recovered. , It is administered to patients. In China, there are reports that the symptoms of severely ill patients have improved although the number of cases is small.

The plan is to get 400 milliliters of blood from about 50 recovered people, give plasma to 50 patients, and examine the safety and efficacy.

The group wants to encourage people who have recovered from next week to donate blood, and start administering it to patients as early as next month.

Dr. Kenshi Kona, who is in charge of clinical research, said, "The treatment method using the antibody of the recovered person is effective even with Ebola hemorrhagic fever, and I expect that it will have a certain effect. It could be a trump card for the treatment of critically ill patients. "